Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V In The Period From March 1, 2025 To December 31, 2026

Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V In The Period From March 1, 2025 To December 31, 2026. Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Enoxaparin Sodium. In Terms Of Contract, Only Those Preparations That Comply With The Specifications Listed Are Expressly In Terms Of Contract.,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Betamethasone Dipropionate + Gentamicin Sulfate,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Diclofenac In The Dosage Forms Hkm, Hkp And Kmp,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Midazolam Amp, Ilo, Iil Not In The Standard Size N3,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Ibuprofen 200 Mg In The Daring Form Fta,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Valproat + Valproic Acid In The Dosage Form Ret